CoChat

Serotonin 2A Receptors, Citalopram and Tryptophan-Depletion: a Multimodal Imaging Study of their Interactions During Response Inhibition

Open access
Macoveanu, Julian, Hornboll, Bettina, Elliott, Rebecca, Erritzoe, David, Paulson, Olaf B, Siebner, Hartwig, Knudsen, Gitte M, Rowe, James B · 2013 · Neuropsychopharmacology
Cited by 47

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Abstract

Poor behavioral inhibition is a common feature of neurological and psychiatric disorders. Successful inhibition of a prepotent response in 'NoGo' paradigms requires the integrity of both the inferior frontal gyrus (IFG) and the serotonergic system. We investigated individual differences in serotonergic regulation of response inhibition. In 24 healthy adults, we used (18)F-altanserin positron emission tomography to assess cerebral 5-HT2A receptors, which have been related to impulsivity. We then investigated the impact of two acute manipulations of brain serotonin levels on behavioral and neural correlates of inhibition using intravenous citalopram and acute tryptophan depletion during functional magnetic resonance imaging. We adapted the NoGo paradigm to isolate effects on inhibition per se as opposed to other aspects of the NoGo paradigm. Successful NoGo inhibition was associated with greater activation of the right IFG compared to control trials with alternative responses, indicating that the IFG is activated with inhibition in NoGo trials rather than other aspects of invoked cognitive control. Activation of the left IFG during NoGo trials was greater with citalopram than acute tryptophan depletion. Moreover, with the NoGo-type of response inhibition, the right IFG displayed an interaction between the type of serotonergic challenge and neocortical 5-HT2A receptor binding. Specifically, acute tryptophan depletion (ATD) produced a relatively larger NoGo response in the right IFG in subjects with low 5-HT2A BPP but reduced the NoGo response in those with high 5-HT2A BPP. These links between serotonergic function and response inhibition in healthy subjects may help to interpret serotonergic abnormalities underlying impulsivity in neuropsychiatric disorders.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/npp.2012.264

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 40

  1. Adams KH, Pinborg LH, Svarer C, Hasselbalch SG, Holm S, Haugbol S et al (2004). A database of [(18)F]-altanserin binding to 5-HT(2A) receptors in normal volunteers: normative data and relationship to physiological and demographic variables. Neuroimage 21: 1105–1113. · DOI
  2. Anderson IM, Clark L, Elliott R, Kulkarni B, Williams SR, Deakin JF (2002). 5-HT(2C) receptor activation by m-chlorophenylpiperazine detected in humans with fMRI. Neuroreport 13: 1547–1551. · DOI · Paper page
  3. Ardis TC, Cahir M, Elliott JJ, Bell R, Reynolds GP, Cooper SJ (2009). Effect of acute tryptophan depletion on noradrenaline and dopamine in the rat brain. J Psychopharmacol 23: 51–55. · DOI · Paper page
  4. Asahi S, Okamoto Y, Okada G, Yamawaki S, Yokota N (2004). Negative correlation between right prefrontal activity during response inhibition and impulsiveness: a fMRI study. Eur Arch Psychiatry Clin Neurosci 254: 245–251. · DOI · Paper page
  5. Attenburrow MJ, Mitter PR, Whale R, Terao T, Cowen PJ (2001). Low-dose citalopram as a 5-HT neuroendocrine probe. Psychopharmacology (Berl) 155: 323–326. · DOI
  6. Blokland A, Lieben C, Deutz NE (2002). Anxiogenic and depressive-like effects, but no cognitive deficits, after repeated moderate tryptophan depletion in the rat. J Psychopharmacol 16: 39–49. · DOI · Paper page
  7. Chamberlain SR, Hampshire A, Muller U, Rubia K, Del Campo N, Craig K et al (2009). Atomoxetine modulates right inferior frontal activation during inhibitory control: a pharmacological functional magnetic resonance imaging study. Biol Psychiatry 65: 550–555. · DOI · Paper page
  8. Chikazoe J, Jimura K, Asari T, Yamashita K, Morimoto H, Hirose S et al (2009). Functional dissociation in right inferior frontal cortex during performance of go/no-go task. Cereb Cortex 19: 146–152. · DOI · Paper page
  9. Chikazoe J, Konishi S, Asari T, Jimura K, Miyashita Y (2007). Activation of right inferior frontal gyrus during response inhibition across response modalities. J Cogn Neurosci 19: 69–80. · DOI · Paper page
  10. Erritzoe D, Holst K, Frokjaer VG, Licht CL, Kalbitzer J, Nielsen FA et al (2010). A nonlinear relationship between cerebral serotonin transporter and 5-HT(2A) receptor binding: an in vivo molecular imaging study in humans. J Neurosci 30: 3391–3397. · DOI · Paper page
  11. Harrison AA, Everitt BJ, Robbins TW (1999). Central serotonin depletion impairs both the acquisition and performance of a symmetrically reinforced go/no-go conditional visual discrimination. Behav Brain Res 100: 99–112. · DOI
  12. Haugbol S, Pinborg LH, Regeur L, Hansen ES, Bolwig TG, Nielsen FA et al (2007). Cerebral 5-HT2A receptor binding is increased in patients with Tourette’s syndrome. Int J Neuropsychopharmacol 10: 245–252. · DOI · Paper page
  13. Henning J, Netter P (2002). Oral application of citalopram (20 mg) and its usefulness for neuroendocrine challenge tests. Int J Neuropsychopharmacol 5: 67–71.
  14. Henson R (2006). Forward inference using functional neuroimaging: dissociations versus associations. Trends Cogn Sci 10: 64–69. · DOI · Paper page
  15. Iversen SD, Mishkin M (1970). Perseverative interference in monkeys following selective lesions of the inferior prefrontal convexity. Exp Brain Res 11: 376–386. · DOI · Paper page
  16. Konishi S, Nakajima K, Uchida I, Kikyo H, Kameyama M, Miyashita Y (1999). Common inhibitory mechanism in human inferior prefrontal cortex revealed by event-related functional MRI. Brain 122: 981–991. · DOI · Paper page
  17. Lamar M, Cutter WJ, Rubia K, Brammer M, Daly EM, Craig MC et al (2009). 5-HT, prefrontal function and aging: fMRI of inhibition and acute tryptophan depletion. Neurobiol Aging 30: 1135–1146. · DOI
  18. Lancaster J, Woldorff M, Parsons L, Liotti M, Freitas C, Rainey L et al (2000). Automated Talairach atlas labels for functional brain mapping. Hum Brain Mapp 10: 120–131. · DOI · Paper page
  19. Langenecker SA, Kennedy SE, Guidotti LM, Briceno EM, Own LS, Hooven T et al (2007). Frontal and limbic activation during inhibitory control predicts treatment response in major depressive disorder. Biol Psychiatry 62: 1272–1280. · DOI · Paper page
  20. LeMarquand DG, Pihl RO, Young SN, Tremblay RE, Seguin JR, Palmour RM et al (1998). Tryptophan depletion, executive functions, and disinhibition in aggressive, adolescent males. Neuropsychopharmacology 19: 333–341. · doi:10.1038/sj.npp.1395196
  21. Leyton M, Okazawa H, Diksic M, Paris J, Rosa P, Mzengeza S et al (2001). Brain regional alpha-[11C]methyl-L-tryptophan trapping in impulsive subjects with borderline personality disorder. Am J Psychiatry 158: 775–782. · DOI · Paper page
  22. Lund TE, Norgaard MD, Rostrup E, Rowe JB, Paulson OB (2005). Motion or activity: their role in intra- and inter-subject variation in fMRI. Neuroimage 26: 960–964. · DOI · Paper page
  23. Marner L, Knudsen GM, Haugbol S, Holm S, Baare W, Hasselbalch SG (2009). Longitudinal assessment of cerebral 5-HT2A receptors in healthy elderly volunteers: an (18F)-altanserin PET study. Eur J Nucl Med Mol Imaging 36: 287–293. · DOI
  24. McKie S, Del-Ben C, Elliott R, Williams S, del Vai N, Anderson I et al (2005). Neuronal effects of acute citalopram detected by pharmacoMRI. Psychopharmacology (Berl) 180: 680–686. · DOI
  25. McNair D, Lorr M, Droppleman L (1971) Manual for the Profile of Mood States. Educational and Industrial Testing Services: San Diego, CA.
  26. Moret C, Briley M (1996). Effects of acute and repeated administration of citalopram on extracellular levels of serotonin in rat brain. Eur J Pharmacol 295: 189–197. · DOI
  27. Nomura M, Nomura Y (2006). Psychological, neuroimaging, and biochemical studies on functional association between impulsive behavior and the 5-HT2A receptor gene polymorphism in humans. Ann N Y Acad Sci 1086: 134–143. · DOI · Paper page
  28. Pinborg LH, Adams KH, Svarer C, Holm S, Hasselbalch SG, Haugbol S et al (2003). Quantification of 5-HT2A receptors in the human brain using [18F]altanserin-PET and the bolus/infusion approach. J Cereb Blood Flow Metab 23: 985–996. · DOI · Paper page
  29. Pinborg LH, Adams KH, Yndgaard S, Hasselbalch SG, Holm S, Kristiansen H et al (2004). (18F)altanserin binding to human 5HT2A receptors is unaltered after citalopram and pindolol challenge. J Cereb Blood Flow Metab 24: 1037–1045. · DOI · Paper page
  30. Pinborg LH, Arfan H, Haugbol S, Kyvik KO, Hjelmborg JV, Svarer C et al (2008). The 5-HT2A receptor binding pattern in the human brain is strongly genetically determined. Neuroimage 40: 1175–1180. · DOI
  31. Rowe J, Friston K, Frackowiak R, Passingham R (2002). Attention to action: specific modulation of corticocortical interactions in humans. Neuroimage 17: 988–998. · DOI · Paper page
  32. Svarer C, Madsen K, Hasselbalch SG, Pinborg LH, Haugbol S, Frokjaer VG et al (2005). MR-based automatic delineation of volumes of interest in human brain PET images using probability maps. Neuroimage 24: 969–979. · DOI · Paper page
  33. Swann N, Tandon N, Canolty R, Ellmore TM, McEvoy LK, Dreyer S et al (2009). Intracranial EEG reveals a time- and frequency-specific role for the right inferior frontal gyrus and primary motor cortex in stopping initiated responses. J Neurosci 29: 12675–12685. · DOI · Paper page
  34. van Donkelaar EL, Blokland A, Ferrington L, Kelly PA, Steinbusch HW, Prickaerts J (2011). Mechanism of acute tryptophan depletion: is it only serotonin? Mol Psychiatry 16: 695–713. · DOI
  35. Wager TD, Sylvester CY, Lacey SC, Nee DE, Franklin M, Jonides J (2005). Common and unique components of response inhibition revealed by fMRI. Neuroimage 27: 323–340. · DOI · Paper page
  36. Walderhaug E, Lunde H, Nordvik JE, Landro NI, Refsum H, Magnusson A (2002). Lowering of serotonin by rapid tryptophan depletion increases impulsiveness in normal individuals. Psychopharmacology (Berl) 164: 385–391. · DOI
  37. Williams WA, Shoaf SE, Hommer D, Rawlings R, Linnoila M (1999). Effects of acute tryptophan depletion on plasma and cerebrospinal fluid tryptophan and 5-hydroxyindoleacetic acid in normal volunteers. J Neurochem 72: 1641–1647. · DOI · Paper page
  38. Wingrove J, Bond AJ, Cleare AJ, Sherwood R (1999). Trait hostility and prolactin response to tryptophan enhancement/depletion. Neuropsychobiology 40: 202–206. · DOI
  39. Zepf FD, Holtmann M, Stadler C, Demisch L, Schmitt M, Wockel L et al (2008). Diminished serotonergic functioning in hostile children with ADHD: tryptophan depletion increases behavioural inhibition. Pharmacopsychiatry 41: 60–65. · DOI
  40. Zheng D, Oka T, Bokura H, Yamaguchi S (2008). The key locus of common response inhibition network for no-go and stop signals. J Cogn Neurosci 20: 1434–1442. · DOI · Paper page

Cited by

See all 47

Metadata

Authors
Macoveanu, J., Hornboll, B., Elliott, R., Erritzoe, D., Paulson, O. B., Siebner, H., Knudsen, G. M., & Rowe, J. B.
Venue
Neuropsychopharmacology
Published
2012-12-19
Volume
38
Issue
6
Pages
996-1005
ISSN
  • 0893-133X (ISSN-L)
  • 1740-634X
OpenAlex
W2053660291
Cited by
47
References
23
FWCI
2.04
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.